Breaking News, Financial News

Financial Report: WuXi PharmaTech

Manufacturing services up 10% in the quarter

By: Kristin Brooks

Managing Editor, Contract Pharma

WuXi PharmaTech
 
2Q Revenues: $194.1 million (+19%)

2Q Earnings: $19.4 million (-34%)

YTD Revenues: $374.2 million (+21%)

YTD Earnings: $37.2 million (-21%)

Comments: Laboratory services grew 18% to $123.5 million in the quarter. Small-molecule manufacturing services increased 10% to $45.9 million. Biologics Services Grew 48% to $18.3 million. New business and other grew 43% to $6.4 million.

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters